Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SKYX Platforms Corp. Director's Dealing 2024

Mar 14, 2024

33953_dirs_2024-03-14_2781ecd4-b0c5-4c26-b97a-c2136a1e22d3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SKYX Platforms Corp. (SKYX)
CIK: 0001598981
Period of Report: 2024-03-12

Reporting Person: SOKOLOW LEONARD J (Director, Co-Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-03-12 Common Stock, no par value F 22325 $1.28 Disposed 759220 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $0.6 2025-11-15 Common Stock, no par value (150000) 150000 Direct
Stock Option (right to buy) $3 2027-04-19 Common Stock, no par value (150000) 150000 Direct
Stock Option (right to buy) $4 2027-04-19 Common Stock, no par value (150000) 150000 Direct
Stock Option (right to buy) $12 2025-01-01 Common Stock, no par value (100000) 100000 Direct
Stock Option (right to buy) $12 2025-12-31 Common Stock, no par value (100000) 100000 Direct
Stock Option (right to buy) $12 2026-12-31 Common Stock, no par value (100000) 100000 Direct
Stock Option (right to buy) $12.34 2027-03-11 Common Stock, no par value (17500) 17500 Direct
Stock Option (right to buy) $3.28 2028-04-05 Common Stock, no par value (17500) 17500 Direct
Stock Option (right to buy) $1.58 2028-09-12 Common Stock, no par value (450000) 450000 Direct
Warrant (right to buy) $9.8 2024-10-26 Common Stock, no par value (1088) 1088 Direct
Warrant (right to buy) $9.8 2024-11-29 Common Stock, no par value (3375) 3375 Direct
Warrant (right to buy) $9.8 2024-12-22 Common Stock, no par value (19827) 19827 Direct
6.0% Subordinated Convertible Promissory Note $15 2023-09-22 Common Stock, no par value () Direct

Footnotes

F1: Exercisable at any time on or prior to the expiration date at the holder's discretion at the adjusted exercise price of $9.80 per share, subject to adjustment provisions (including certain anti-dilution provisions).

F2: The principal amount, plus any accrued and unpaid interest, is convertible into shares of common stock at any time on or prior to the maturity date at the holder's discretion at the conversion price of $15.00 per share.

F3: Represents the principal amount of the convertible note and excludes interest that may accrue. Interest on the note is payable annually, in cash or common stock, at the holder's discretion.

F4: Options vest in twelve equal monthly installments, beginning on the last day of the month in which the options were granted.

F5: Options vest over 3.5 years as follows, subject to continued employment through the vesting date: 120,000 vested on September 12, 2023; 300,000 vest in six semi-annual installments of 50,000, beginning on March 12, 2024; and 30,000 vest on March 12, 2027.

F6: Includes 10,084 restricted shares granted in consideration for services to be provided to the issuer pursuant to a corporate advisory agreement between the issuer and Newbridge Securities Corporation dated November 9, 2022. The restricted shares vest on the following schedule: one quarter of the shares on each of November 9, 2022 and the six-, 12- and 18-month anniversaries of such date. If the agreement is terminated prior to its expiration, any shares that have not vested as of such date will be forfeited.

F7: Includes 280,000 restricted stock units ("RSUs"), which will vest as follows, subject to continued employment through the vesting date: 250,000 vest in five semi-annual installments of 50,000 beginning on September 12, 2024 and 30,000 vest on March 12, 2027.

F8: The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of RSUs by directing the issuer to withhold shares otherwise issuable upon vesting of the grant.